Related Experiment Video

Updated: May 20, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
10:13

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples

Published on: December 2, 2022

Cancer resistance to type II topoisomerase inhibitors

P Pilati1, D Nitti, S Mocellin

  • 1Department of Oncological and Surgical Sciences, University of Padova, Italy.

Current Medicinal Chemistry
|July 14, 2012
PubMed

Insights

Type II topoisomerases (TOPO2) are crucial for DNA management and are targeted by chemotherapy. Understanding resistance mechanisms to TOPO2 inhibitors is vital for improving cancer treatment efficacy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Type II topoisomerases (TOPO2) are essential enzymes involved in managing DNA topology during vital cellular processes like replication, transcription, and repair.
  • TOPO2 inhibitors represent a significant class of chemotherapy agents used in treating various cancers, highlighting their clinical importance.
  • Drug resistance to TOPO2 inhibitors poses a major challenge, limiting treatment efficacy and patient survival rates.

Purpose of the Study:

  • To elucidate the molecular biology of TOPO2 inhibitors, providing a foundation for understanding cancer resistance.
  • To comprehensively review and discuss current evidence on the mechanisms of resistance to TOPO2-targeting drugs.
  • To explore potential clinical strategies for overcoming resistance to TOPO2 inhibitors.

Main Methods:

  • Literature review and synthesis of existing research on TOPO2 molecular biology.
  • Analysis of documented mechanisms of cancer drug resistance to TOPO2 inhibitors.
  • Discussion of clinical data and strategies related to TOPO2 inhibitor resistance.

Main Results:

  • Detailed summary of the molecular mechanisms of action for various TOPO2 inhibitors.
  • Identification and categorization of diverse resistance mechanisms, including genetic and epigenetic alterations.
  • Exploration of emerging strategies to circumvent drug resistance in preclinical and clinical settings.

Conclusions:

  • A thorough understanding of TOPO2 inhibitor molecular biology is fundamental to addressing cancer resistance.
  • Multiple resistance mechanisms exist, necessitating tailored therapeutic approaches.
  • Developing strategies to overcome resistance is critical for enhancing the effectiveness of TOPO2-targeted cancer therapies.

More Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...